Evotec SE ( EVOTF) - Key Metrics
EVOTF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.81 | -$0.26 | -$0.61 | -$0.66 |
| 2026Q1 | $0.89 | -$0.69 | -$0.01 | -$0.04 |
| 2025Q4 | $1.42 | $0.08 | $0.36 | $0.28 |
| 2025Q3 | $0.92 | -$0.24 | -$0.38 | -$0.49 |
| 2025Q2 | $0.96 | -$0.24 | $0.15 | $0.02 |
EVOTF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.63 |
| 2026Q1 | 0% | -1.64 |
| 2025Q4 | 0% | 20.71 |
| 2025Q3 | 0% | -6.46 |
| 2025Q2 | 0% | -7.31 |
EVOTF
Price: $3.32
52 week price:
Earnings Per Share: -1.26 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.2 billion